ARS Pharmaceuticals (SPRY) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free SPRY Stock Alerts $9.06 -0.41 (-4.33%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ARS Pharmaceuticals Short Interest DataCurrent Short Volume6,090,000 sharesPrevious Short Volume5,500,000 sharesChange Vs. Previous Month+10.73%Dollar Volume Sold Short$56.27 millionShort Interest Ratio / Days to Cover9.0Last Record DateApril 15, 2024Outstanding Shares96,894,000 sharesFloat Size42,160,000 sharesShort Percent of Float14.44%Today's Trading Volume352,386 sharesAverage Trading Volume599,829 sharesToday's Volume Vs. Average59% Short Selling ARS Pharmaceuticals ? Sign up to receive the latest short interest report for ARS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSPRY Short Interest Over TimeSPRY Days to Cover Over TimeSPRY Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. ARS Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,090,000 shares $56.27 million +10.7%14.4%9 $9.24 3/31/20245,500,000 shares $56.21 million +29.4%13.1%8.5 $10.22 3/15/20244,250,000 shares $38.93 million -7.8%10.2%7.3 $9.16 2/29/20244,610,000 shares $38.59 million -5.1%11.2%10 $8.37 2/15/20244,860,000 shares $35.28 million No Change11.8%11.3 $7.26 1/31/20244,860,000 shares $30.18 million -30.0%11.8%11.4 $6.21 Get the Latest News and Ratings for SPRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,940,000 shares $41.02 million -0.4%16.9%13.8 $5.91 12/31/20236,970,000 shares $38.20 million +4.3%16.9%12.6 $5.48 12/15/20236,680,000 shares $34.80 million +10.8%16.2%9.3 $5.21 11/30/20236,030,000 shares $29.12 million +1.5%14.7%4.4 $4.83 11/15/20235,940,000 shares $26.91 million -10.0%14.6%4.3 $4.53 10/31/20236,600,000 shares $23.56 million +16.4%16.2%5 $3.57 10/15/20235,670,000 shares $21.15 million -3.4%14.0%4.6 $3.73 9/30/20235,870,000 shares $22.19 million +1.6%14.5%4.9 $3.78 9/15/20235,780,000 shares $41.96 million +7.6%14.2%5.1 $7.26 8/31/20235,370,000 shares $38.07 million -7.7%10.4%10.2 $7.09 8/15/20235,820,000 shares $40.97 million -4.1%12.2%9.7 $7.04 7/31/20236,070,000 shares $44.61 million -2.7%12.8%3.7 $7.35 7/15/20236,240,000 shares $42.62 million +5.2%13.1%3.8 $6.83 6/30/20235,930,000 shares $39.73 million +9.4%12.5%3.7 $6.70 6/15/20235,420,000 shares $32.79 million +22.4%11.4%3.4 $6.05 5/31/20234,430,000 shares $30.83 million +22.4%9.4%3 $6.96 5/15/20233,620,000 shares $28.27 million No Change7.7%2.7 $7.81 SPRY Short Interest - Frequently Asked Questions What is ARS Pharmaceuticals' current short interest? Short interest is the volume of ARS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 6,090,000 shares of SPRY short. 14.44% of ARS Pharmaceuticals' shares are currently sold short. Learn More on ARS Pharmaceuticals' current short interest. What is a good short interest ratio for ARS Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPRY shares currently have a short interest ratio of 9.0. Learn More on ARS Pharmaceuticals's short interest ratio. Which institutional investors are shorting ARS Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ARS Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ARS Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.44% of ARS Pharmaceuticals' floating shares are currently sold short. Is ARS Pharmaceuticals' short interest increasing or decreasing? ARS Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 6,090,000 shares, an increase of 10.7% from the previous total of 5,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ARS Pharmaceuticals' float size? ARS Pharmaceuticals currently has issued a total of 96,894,000 shares. Some of ARS Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ARS Pharmaceuticals currently has a public float of 42,160,000 shares. How does ARS Pharmaceuticals' short interest compare to its competitors? 14.44% of ARS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ARS Pharmaceuticals: Immunome, Inc. (4.42%), Sage Therapeutics, Inc. (18.98%), OPKO Health, Inc. (23.81%), ALX Oncology Holdings Inc. (13.47%), Tango Therapeutics, Inc. (19.37%), Enliven Therapeutics, Inc. (18.33%), 89bio, Inc. (11.77%), Arcutis Biotherapeutics, Inc. (17.02%), Zentalis Pharmaceuticals, Inc. (23.43%), Tyra Biosciences, Inc. (13.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ARS Pharmaceuticals stock? Short selling SPRY is an investing strategy that aims to generate trading profit from ARS Pharmaceuticals as its price is falling. SPRY shares are trading down $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ARS Pharmaceuticals? A short squeeze for ARS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRY, which in turn drives the price of the stock up even further. How often is ARS Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Immunome Short Interest Data Sage Therapeutics Short Interest Data OPKO Health Short Interest Data ALX Oncology Short Interest Data Tango Therapeutics Short Interest Data Enliven Therapeutics Short Interest Data 89bio Short Interest Data Arcutis Biotherapeutics Short Interest Data Zentalis Pharmaceuticals Short Interest Data Tyra Biosciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SPRY) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold